• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (3)
    • Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice.
    • Communicating with participants during the conduct of multi-center clinical trials.
    • The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.
    • See All 3 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Communicating with participants during the conduct of multi-center clinical trials.

Communicating with participants during the conduct of multi-center clinical trials. Clin Trials. 2016 12; 13(6):592-596.

View in: PubMed

subject areas
  • Canada
  • Clinical Trials as Topic
  • Communication
  • Creatine
  • Double-Blind Method
  • Humans
  • Information Dissemination
  • Informed Consent
  • Longitudinal Studies
  • Multicenter Studies as Topic
  • Parkinson Disease
  • Patient Participation
  • Randomized Controlled Trials as Topic
  • Research Subjects
  • Telecommunications
  • United States

authors with profiles
  • Jordan J. Elm
  • Barbara C. Tilley